GlassScriptPhysician profile
Sheldon Jeffrey Siegel
NPI 1932110582
$1,123.27
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,099 · 2020: $24.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $617.00 | 2019 | |
| Smith+Nephew, INC. | $170.72 | 2019-2020 | |
| Wright Medical Technology, INC. | $121.35 | 2019 | |
| Osiris Therapeutics INC. | $66.90 | 2019 | |
| Stryker Corporation | $36.15 | 2019 | |
| Depuy Synthes Sales INC. | $27.17 | 2019 | |
| Bioventus LLC | $18.70 | 2019 | |
| Melinta Therapeutics, LLC | $18.04 | 2019 | |
| Integra Lifesciences Corporation | $14.87 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $13.00 | 2019 | |
| Kci USA, INC. | $11.87 | 2019 | |
| Orthofix Medical, INC. | $7.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Siegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.